Matthew Winkler - 12 Jun 2023 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Matthew Winkler, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
12 Jun 2023
Net transactions value
+$1,016,940
Form type
4
Filing time
12 Jun 2023, 18:16:44 UTC
Previous filing
05 Jun 2023
Next filing
05 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Purchase $1,016,940 +203,388 +26% $5.00 984,513 12 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.